Ticker Report StockNews.com initiated coverage on shares of Paratek Pharmaceuticals (NASDAQ:PRTK Free Report) in a report released on Tuesday morning. The firm issued a hold rating on the specialty...\n more…
Ticker Report Deltec Asset Management LLC purchased a new stake in shares of Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK Free Report) during the 2nd quarter, according to its most recent 13F filing with the...\n more…
Ticker Report StockNews.com assumed coverage on shares of Paratek Pharmaceuticals (NASDAQ:PRTK Free Report) in a research report report published on Monday morning. The brokerage issued a hold rating on...\n more…
Globe Newswire CAMBRIDGE, Mass., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Gurnet Point Capital ( Gurnet Point ) and Novo Holdings A/S ( Novo Holdings ) announced today the completion of their acquisition of Paratek...\n more…
Globe Newswire BOSTON, Sept. 18, 2023 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. ( Paratek ) (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of...\n more…